Clover Health Investments Corp (NASDAQ:CLOV) traded at $0.68 at close of the session on Friday, April 26, made an upward move of 1.49% on its previous day’s price.
Looking at the stock we see that its previous close was $0.67 . In terms of its 52-week price range, CLOV has a high of $1.63 and a low of $0.61. The company’s stock has lost about -14.25% over that past 30 days.
Clover Health Investments Corp has a market cap of $335.59 million. Estimates by analysts give the company expected earnings per share (EPS) of -$0.07, with the EPS growth for the year raised at -$0.22 for 2024 and -$0.2 for next year. These figures represent 50.00% and 9.10% growth in EPS for the two years respectively.
Analysts tracking the company’s growth have also given it a consensus growth in revenue estimated at $321.23 million, with a low of $316.1 million and a high of $325.59 million. The median projection represents growth adding up to -39.10% compared to sales growth for the corresponding quarter a year ago. According to analyst consensus estimates figures, the company’s yearly revenue forecast for 2024 is expected to hit $1.28 billion, or -37.30% down from figures reported last year.
On the other hand, looking at the outlook for the CLOV stock, short term indicators assign the stock an average of 100% Sell, while medium term indicators assign it an average of 100% Sell. Long term indicators on average place the stock in the category of 100% Sell.
Looking further, we note the current price level is -1.72% off its SMA20 and -13.68% from its 50-day simple moving average. The RSI (14) is pointing at 43.69 while the volatility over the past week is 6.18% and jumps to 5.48% over the past one month. The beta value is 1.86, while the average true range (ATR) is currently pointing at 0.04.
Coming back to Clover Health Investments Corp (NASDAQ:CLOV), we note that the average 3-month trading volume was 9.29 million. Current shares outstanding are 393.27 million.
The insiders hold 23.70% of the company’s shares while institutions hold 19.64%. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock -28.58% down in year-to-date price movement.
